Clinical Trials Committee – 2017 Meeting Dates & Deadlines
The HREBA – Clinical Trials Committee (CTC) only accepts new submissions through IRISS. The CTC office must receive all new study applications together with all supporting documents before 4 pm on the submission date.
This is the current schedule:
|Meeting Date||Submission Deadline|
|(Third Friday of the month except where indicated by *)||(Fourth Tuesday prior to meeting except where indicated by *)|
|20 January 2017||20 December 2016|
|10 February 2017 *||24 January 2017|
|17 March 2017||21 February 2017|
|21 April 2017||28 March 2017|
|12 May 2017||25 April 2017|
|16 June 2017||23 May 2017|
|21 July 2017||27 June 2017|
|18 August 2017||25 July 2017|
|15 September 2017||22 August 2017|
|20 October 2017||26 September 2017|
|17 November 2017||24 October 2017|
|15 December 2017||21 November 2017 *|
|19 January 2018||19 December 2017 *|
A print version is available here.
After meeting, the CTC will notify Investigators of the results of the review within one week.
Note: Effective June 15, 2001, in accordance with Section 50(4) of The Health Information Act, the CTC provides to the Information and Privacy Commissioner, copies of approvals granted by the Committee, including final letters of approval, annual re-approvals and notification of termination/completion of studies.
The applicable fees listed below are required with the submission of documents for review. Processing and review will not proceed until the Primary Investigator issues payment to Alberta Innovates. All fees include the GST.
Full Review: $6190.00
Full Review – Extension Studies & Sub-studies (if submitted simultaneously with original protocol): $1185.00
Expedited Review: $2960.00
Reciprocal Review: $1200.00
Additional Qualified Investigator Review: $590.00
Assessment of Protocol: $615.00
Amendment Review: $1185.00
Annual Review: $340.00
Final Review: $335.00
Waiver of Fees
The CTC may reduce or waive fees for studies being conducted on a smaller financial scale or for which no funding is available.
The relevant fee, however, must be included when submitting the study documents and the Primary Investigator must provide a written request for reduction or waiver of fees to:
Wendy Burrill, Associate Director, Research Ethics
Health Research Ethics Board of Alberta
1500 – 10104 103 Avenue NW
Edmonton, Alberta, T5J 4A7
After review and approval of a request for reduction or waiver of a fee, Alberta Innovates will return/refund the applicable amount.